Hanson & Doremus Investment Management Eli Lilly & CO Transaction History

Hanson & Doremus Investment Management

$637 Million
Q4 2024

A detailed history of Hanson & Doremus Investment Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 3,262 shares of LLY stock, worth $2.5 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

3,262

Previous 3,407 4.26%

Holding current value

$2.5 Million

Previous $3.02 Million 16.57%

% of portfolio

0.4%

Previous 0.48%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$727.2 - $932.06 $105,444 - $135,148	-145 Reduced 4.26%	3,262 $2.52 Million
Q2 2024 Aug 08, 2024	BUY	$724.87 - $909.04 $5,074 - $6,363	7 Added 0.21%	3,407 $3.08 Million
Q1 2024 Apr 22, 2024	BUY	$592.2 - $792.28 $1,776 - $2,376	3 Added 0.09%	3,400 $2.65 Million
Q4 2023 Jan 25, 2024	SELL	$525.19 - $619.13 $53,569 - $63,151	-102 Reduced 2.92%	3,397 $1.98 Million
Q2 2023 Jul 18, 2023	SELL	$350.74 - $468.98 $5,611 - $7,503	-16 Reduced 0.46%	3,499 $1.64 Million
Q1 2023 Apr 18, 2023	SELL	$310.63 - $364.82 $8,697 - $10,214	-28 Reduced 0.79%	3,515 $1.21 Million
Q4 2022 Jan 18, 2023	SELL	$321.55 - $374.67 $248,879 - $289,994	-774 Reduced 17.93%	3,543 $1.3 Million
Q3 2022 Oct 20, 2022	SELL	$296.48 - $337.87 $93,391 - $106,429	-315 Reduced 6.8%	4,317 $1.4 Million
Q1 2022 Apr 22, 2022	SELL	$234.69 - $291.66 $53,978 - $67,081	-230 Reduced 4.73%	4,632 $1.33 Million
Q4 2021 Jan 20, 2022	SELL	$224.85 - $279.04 $22,709 - $28,183	-101 Reduced 2.04%	4,862 $1.34 Million
Q3 2021 Oct 21, 2021	SELL	$221.6 - $272.71 $74,236 - $91,357	-335 Reduced 6.32%	4,963 $1.15 Million
Q2 2021 Jul 22, 2021	BUY	$180.55 - $233.54 $60,484 - $78,235	335 Added 6.75%	5,298 $784,000
Q1 2021 May 03, 2021	SELL	$164.32 - $212.72 $10,680 - $13,826	-65 Reduced 1.29%	4,963 $927,000
Q4 2020 Feb 01, 2021	SELL	$130.46 - $172.63 $35,224 - $46,610	-270 Reduced 5.1%	5,028 $849,000
Q2 2020 Jul 17, 2020	SELL	$136.42 - $164.18 $14,460 - $17,403	-106 Reduced 1.96%	5,298 $870,000
Q4 2019 Jan 16, 2020	BUY	$106.92 - $132.43 $37,101 - $45,953	347 Added 6.86%	5,404 $710,000
Q3 2019 Oct 18, 2019	SELL	$106.79 - $116.16 $1,067 - $1,161	-10 Reduced 0.2%	5,057 $566,000
Q2 2019 Jul 18, 2019	BUY	$110.79 - $129.32 $102,702 - $119,879	927 Added 22.39%	5,067 $561,000
Q1 2019 Apr 23, 2019	BUY	$111.31 - $131.02 $15,249 - $17,949	137 Added 3.42%	4,140 $0
Q3 2018 Oct 24, 2018	SELL	$85.86 - $107.31 $3,863 - $4,828	-45 Reduced 1.11%	4,003 $0
Q3 2017 Oct 26, 2017	BUY	$77.07 - $85.54 $311,979 - $346,265	4,048	4,048 $0

Others Institutions Holding LLY

# of Institutions

4,029

Shares Held

739M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $728B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Hanson & Doremus Investment Management with notifications on news.

Account

Hanson & Doremus Investment Management Eli Lilly & CO Transaction History